These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165 [TBL] [Abstract][Full Text] [Related]
3. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628 [TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant peripheral nerve sheath tumors in pediatric NF1 disease. Martin E; Flucke UE; Coert JH; van Noesel MM Childs Nerv Syst; 2020 Oct; 36(10):2453-2462. PubMed ID: 32494969 [TBL] [Abstract][Full Text] [Related]
5. New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. Williams KB; Largaespada DA Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32353955 [TBL] [Abstract][Full Text] [Related]
6. RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST. Chung MH; Aimaier R; Yu Q; Li H; Li Y; Wei C; Gu Y; Wang W; Guo Z; Long M; Li Q; Wang Z Cell Oncol (Dordr); 2023 Oct; 46(5):1399-1413. PubMed ID: 37086345 [TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Jones J; Cain S; Pesic-Smith J; Choong PFM; Morokoff AP; Drummond KJ; Dabscheck G J Neurooncol; 2021 Sep; 154(3):265-274. PubMed ID: 34529228 [TBL] [Abstract][Full Text] [Related]
8. Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Miller DT; Cortés-Ciriano I; Pillay N; Hirbe AC; Snuderl M; Bui MM; Piculell K; Al-Ibraheemi A; Dickson BC; Hart J; Jones K; Jordan JT; Kim RH; Lindsay D; Nishida Y; Ullrich NJ; Wang X; Park PJ; Flanagan AM Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32252413 [TBL] [Abstract][Full Text] [Related]
9. FOXM1 promotes neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor progression in a NUF2-dependent manner. Aimaier R; Chung MH; Gu Y; Yu Q; Wei C; Li H; Guo Z; Long M; Li Y; Wang W; Li Q; Wang Z Cancer Gene Ther; 2023 Oct; 30(10):1390-1402. PubMed ID: 37488294 [TBL] [Abstract][Full Text] [Related]
10. Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation. Magallón-Lorenz M; Fernández-Rodríguez J; Terribas E; Creus-Batchiller E; Romagosa C; Estival A; Perez Sidelnikova D; Salvador H; Villanueva A; Blanco I; Carrió M; Lázaro C; Serra E; Gel B Hum Genet; 2021 Aug; 140(8):1241-1252. PubMed ID: 34059954 [TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a recurrent malignant peripheral nerve sheath tumor cell line: RsNF. Zhang X; Hu C; Li D; Liu S Hum Cell; 2024 Jan; 37(1):345-355. PubMed ID: 37938540 [TBL] [Abstract][Full Text] [Related]
12. Malignant Peripheral Nerve Sheath Tumors of the Brachial Plexus: A Single-Center Experience on Diagnosis, Management, and Outcomes. Donaldson EK; Winter JM; Chandler RM; Clark TA; Giuffre JL Ann Plast Surg; 2023 Apr; 90(4):339-342. PubMed ID: 36752552 [TBL] [Abstract][Full Text] [Related]
14. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850 [TBL] [Abstract][Full Text] [Related]
15. Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart. Agaram NP; Wexler LH; Chi P; Antonescu CR Genes Chromosomes Cancer; 2023 Mar; 62(3):131-138. PubMed ID: 36414547 [TBL] [Abstract][Full Text] [Related]
16. Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Widemann BC Curr Oncol Rep; 2009 Jul; 11(4):322-8. PubMed ID: 19508838 [TBL] [Abstract][Full Text] [Related]
17. Experience of a single center in the treatment of rare malignant peripheral nerve sheath tumors during the years 1991-2021. Ptchelintseva A; Nuutinen H; Salo J; Tukiainen E J Plast Surg Hand Surg; 2023; 57(1-6):376-382. PubMed ID: 36244030 [TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study. Martin E; Coert JH; Flucke UE; Slooff WM; van de Sande MAJ; van Noesel MM; Grünhagen DJ; Wijnen MHWA; Verhoef C Pediatr Blood Cancer; 2020 Apr; 67(4):e28138. PubMed ID: 31889416 [TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumor of the maxilla: Case report and review of the literature with emphasis on its poor prognosis. Oh KY; Hong SD Oral Oncol; 2022 Dec; 135():106211. PubMed ID: 36257181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]